Ticker Details
ProKidney Corp. Class A Ordinary Shares
IPO Date:	June 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$269.69M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 5.26%
Avg Daily Range (30 D):	$0.08 | 4.12%
Avg Daily Range (90 D):	$0.08 | 3.64%

Institutional Daily Volume
Avg Daily Volume:	1.24M
Avg Daily Volume (30 D):	.74M
Avg Daily Volume (90 D):	.89M

Trade Size
Avg Trade Size (Sh.):	182
Avg Trade Size (Sh.) (30 D):	134
Avg Trade Size (Sh.) (90 D):	152

Institutional Trades
Total Institutional Trades:	145
Avg Institutional Trade:	$2.06M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$.64M
Avg Institutional Trade Volume:	.52M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.32M
Avg Closing Trade (30 D):	$.62M
Avg Closing Trade (90 D):	$.62M
Avg Closing Volume:	880.02K

News

Mar 18, 2026 @ 8:00 PM ProKidney Reports Full Year 2025 Financial Results... Source: Prokidney Corp.

Nov 6, 2025 @ 4:00 PM ProKidney Presents Full Results from the Phase 2 R... Source: Prokidney Corp.

Jun 21, 2024 @ 10:55 AM Play Likely Earnings Beat With 3 Top-Ranked Stocks... Source: Sanghamitra Saha

Jun 12, 2024 @ 1:35 AM ProKidney Announces Pricing of its Upsized $130 Mi... Source: ProKidney

Jun 10, 2024 @ 8:15 PM ProKidney Announces Proposed $125 Million Public O... Source: ProKidney

Financials
	TTM	Q4 2025	FY 2025
Basic EPS
Diluted EPS
Revenue	$.89M	$.23M	$.89M
Gross Profit
Net Income / Loss	$-151.61M	$-40.85M	$-151.61M
Operating Income / Loss	$-165.01M	$-45.37M	$-165.01M
Cost of Revenue
Net Cash Flow	$9.42M	$13.21M	$9.42M
PE Ratio